T-cell surface CCR5 density is not correlated with hepatitis severity in hepatitis C virus/HIV-coinfected individuals : Implications for the therapeutic use of CCR5 antagonists
- Author
- VINCENT, Thierry1 2 3 ; PORTALES, Pierre2 3 ; BAILLAT, Vincent2 3 ; MERLE DE BOEVER, Corinne2 3 ; LE MOING, Vincent2 3 ; VIDAL, Michèle2 3 ; DUCOS, Jacques4 ; CLOT, Jacques2 3 ; REYNES, Jacques2 3 ; CORBEAU, Pierre1 2 3
[1] Institut de Génétique Humaine, CNRS UPR 1142, Montpellier, France
[2] Laboratoire d'Immunologie, Hôpital Saint Eloi, Montpellier, France
[3] Service des Maladies Infectieuses et Tropicales, Hôpital Gui de Chauliac, Montpellier, France
[4] Laboratoire de Virologie, Hôpital Lapeyronie, Montpellier, France - Source
Journal of acquired immune deficiency syndromes (1999). 2005, Vol 38, Num 3, pp 305-309, 5 p ; ref : 21 ref
- ISSN
- 1525-4135
- Scientific domain
- Immunology, immunopathology, allergology; Virology
- Publisher
- Lippincott Williams & Wilkins, Hagerstown, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Author keyword
- HIV entry inhibitor chemokine receptor chemokine hepatitis C virus host factor liver
- Keyword (fr)
- Chimiokine Foie Lymphocyte T Microbiologie Récepteur chimiokine CCR5 Récepteur chimiokine Surface cellulaire Virologie Virus hépatite C Virus immunodéficience humaine Appareil digestif Flaviviridae Hepacivirus Lentivirus Retroviridae Virus
- Keyword (en)
- Chemokine Liver T-Lymphocyte Microbiology CCR5 chemokine receptor Chemokine receptor Cell surface Virology Hepatitis C virus Human immunodeficiency virus Digestive system Flaviviridae Hepacivirus Lentivirus Retroviridae Virus
- Keyword (es)
- Quimioquina Hígado Linfocito T Microbiología Receptor quimioquina CCR5 Receptor quimioquina Superficie celular Virología Hepatitis C virus Human immunodeficiency virus Aparato digestivo Flaviviridae Hepacivirus Lentivirus Retroviridae Virus
- Classification
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A05 Microbiology / 002A05C Virology / 002A05C10 Miscellaneous
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B05 Infectious diseases / 002B05C Viral diseases / 002B05C02 Human viral diseases / 002B05C02J Miscellaneous
- Discipline
- Infectious pathology Microbiology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 16586076
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:176:\"T-cell surface CCR5 density is not correlated with hepatitis severity in hepatitis C virus\/HIV-coinfected individuals : Implications for the therapeutic use of CCR5 antagonists\";s:9:\"\u0000*\u0000jtitle\";s:54:\"Journal of acquired immune deficiency syndromes (1999)\";s:9:\"\u0000*\u0000stitle\";s:38:\"J. acquir. immune defic. syndr. (1999)\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"38\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"305\";s:8:\"\u0000*\u0000epage\";s:3:\"309\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1525-4135\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"VINCENT\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Thierry\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:16:\"PORTALES, Pierre\";i:1;s:16:\"BAILLAT, Vincent\";i:2;s:24:\"MERLE DE BOEVER, Corinne\";i:3;s:17:\"LE MOING, Vincent\";i:4;s:15:\"VIDAL, Mich\u00e8le\";i:5;s:14:\"DUCOS, Jacques\";i:6;s:13:\"CLOT, Jacques\";i:7;s:15:\"REYNES, Jacques\";i:8;s:15:\"CORBEAU, Pierre\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:176:\"T-cell surface CCR5 density is not correlated with hepatitis severity in hepatitis C virus\/HIV-coinfected individuals : Implications for the therapeutic use of CCR5 antagonists\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:176:\"T-cell surface CCR5 density is not correlated with hepatitis severity in hepatitis C virus\/HIV-coinfected individuals : Implications for the therapeutic use of CCR5 antagonists\";s:9:\"\u0000*\u0000jtitle\";s:54:\"Journal of acquired immune deficiency syndromes (1999)\";s:9:\"\u0000*\u0000stitle\";s:38:\"J. acquir. immune defic. syndr. (1999)\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"38\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"305\";s:8:\"\u0000*\u0000epage\";s:3:\"309\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1525-4135\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"VINCENT\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Thierry\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:16:\"PORTALES, Pierre\";i:1;s:16:\"BAILLAT, Vincent\";i:2;s:24:\"MERLE DE BOEVER, Corinne\";i:3;s:17:\"LE MOING, Vincent\";i:4;s:15:\"VIDAL, Mich\u00e8le\";i:5;s:14:\"DUCOS, Jacques\";i:6;s:13:\"CLOT, Jacques\";i:7;s:15:\"REYNES, Jacques\";i:8;s:15:\"CORBEAU, Pierre\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:176:\"T-cell surface CCR5 density is not correlated with hepatitis severity in hepatitis C virus\/HIV-coinfected individuals : Implications for the therapeutic use of CCR5 antagonists\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:176:\"T-cell surface CCR5 density is not correlated with hepatitis severity in hepatitis C virus\/HIV-coinfected individuals : Implications for the therapeutic use of CCR5 antagonists\";s:9:\"\u0000*\u0000jtitle\";s:54:\"Journal of acquired immune deficiency syndromes (1999)\";s:9:\"\u0000*\u0000stitle\";s:38:\"J. acquir. immune defic. syndr. (1999)\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"38\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"305\";s:8:\"\u0000*\u0000epage\";s:3:\"309\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1525-4135\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"VINCENT\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Thierry\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:16:\"PORTALES, Pierre\";i:1;s:16:\"BAILLAT, Vincent\";i:2;s:24:\"MERLE DE BOEVER, Corinne\";i:3;s:17:\"LE MOING, Vincent\";i:4;s:15:\"VIDAL, Mich\u00e8le\";i:5;s:14:\"DUCOS, Jacques\";i:6;s:13:\"CLOT, Jacques\";i:7;s:15:\"REYNES, Jacques\";i:8;s:15:\"CORBEAU, Pierre\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:176:\"T-cell surface CCR5 density is not correlated with hepatitis severity in hepatitis C virus\/HIV-coinfected individuals : Implications for the therapeutic use of CCR5 antagonists\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:176:\"T-cell surface CCR5 density is not correlated with hepatitis severity in hepatitis C virus\/HIV-coinfected individuals : Implications for the therapeutic use of CCR5 antagonists\";s:9:\"\u0000*\u0000jtitle\";s:54:\"Journal of acquired immune deficiency syndromes (1999)\";s:9:\"\u0000*\u0000stitle\";s:38:\"J. acquir. immune defic. syndr. (1999)\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"38\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"305\";s:8:\"\u0000*\u0000epage\";s:3:\"309\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1525-4135\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"VINCENT\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Thierry\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:16:\"PORTALES, Pierre\";i:1;s:16:\"BAILLAT, Vincent\";i:2;s:24:\"MERLE DE BOEVER, Corinne\";i:3;s:17:\"LE MOING, Vincent\";i:4;s:15:\"VIDAL, Mich\u00e8le\";i:5;s:14:\"DUCOS, Jacques\";i:6;s:13:\"CLOT, Jacques\";i:7;s:15:\"REYNES, Jacques\";i:8;s:15:\"CORBEAU, Pierre\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:176:\"T-cell surface CCR5 density is not correlated with hepatitis severity in hepatitis C virus\/HIV-coinfected individuals : Implications for the therapeutic use of CCR5 antagonists\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:176:\"T-cell surface CCR5 density is not correlated with hepatitis severity in hepatitis C virus\/HIV-coinfected individuals : Implications for the therapeutic use of CCR5 antagonists\";s:9:\"\u0000*\u0000jtitle\";s:54:\"Journal of acquired immune deficiency syndromes (1999)\";s:9:\"\u0000*\u0000stitle\";s:38:\"J. acquir. immune defic. syndr. (1999)\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"38\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"305\";s:8:\"\u0000*\u0000epage\";s:3:\"309\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1525-4135\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"VINCENT\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Thierry\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:16:\"PORTALES, Pierre\";i:1;s:16:\"BAILLAT, Vincent\";i:2;s:24:\"MERLE DE BOEVER, Corinne\";i:3;s:17:\"LE MOING, Vincent\";i:4;s:15:\"VIDAL, Mich\u00e8le\";i:5;s:14:\"DUCOS, Jacques\";i:6;s:13:\"CLOT, Jacques\";i:7;s:15:\"REYNES, Jacques\";i:8;s:15:\"CORBEAU, Pierre\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:176:\"T-cell surface CCR5 density is not correlated with hepatitis severity in hepatitis C virus\/HIV-coinfected individuals : Implications for the therapeutic use of CCR5 antagonists\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
